Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Ma Donghui"'
Publikováno v:
中国工程科学, Vol 25, Iss 3, Pp 209-218 (2023)
Given the frequent occurrence of natural disasters and public emergencies, China’s land space security is facing severe challenges, especially in terms of disaster risk prevention and control as well as the planning and development of land space re
Externí odkaz:
https://doaj.org/article/9350393cb23244a0a34bd25c80e82613
Publikováno v:
In International Journal of Disaster Risk Reduction 15 October 2024 113
Autor:
Riedesel, Ludwig, Ma, Donghui, Piepho, Hans-Peter, Laidig, Friedrich, Möller, Markus, Golla, Burkhard, Kautz, Timo, Feike, Til
Publikováno v:
In Field Crops Research 1 October 2024 317
Publikováno v:
In Journal of Loss Prevention in the Process Industries December 2024 92
Autor:
Htut, Thin Thin, Tanaka, Satoyuki, Ma, Donghui, Okada, Jun, Honnami, Masahito, Shinoda, Kaoru, Abe, Masamitsu, Katayama, Takeru
Publikováno v:
In Engineering Failure Analysis July 2024 161
Publikováno v:
In International Journal of Biological Macromolecules April 2024 263 Part 1
Publikováno v:
In International Journal of Disaster Risk Reduction March 2024 103
Autor:
Htut, Thin Thin, Tanaka, Satoyuki, Ma, Donghui, Okada, Jun, Honnami, Masahito, Shinoda, Kaoru, Abe, Masamitsu, Katayama, Takeru
Publikováno v:
In Engineering Failure Analysis January 2024 155
Publikováno v:
In International Journal of Fatigue December 2023 177
Autor:
Ma Donghui, Baruch Dror, Shu Youmin, Yuan Kehu, Sun Zairen, Ma Kaiyan, Hoang Toan, Fu Wei, Min Li, Lan Zhu-Sheng, Wang Fangxun, Mull Lori, He Wei-Wu
Publikováno v:
BMC Biotechnology, Vol 12, Iss 1, p 88 (2012)
Abstract Background An antibody with cross-reactivity can create unexpected side effects or false diagnostic reports if used for clinical purposes. ERCC1 is being explored as a predictive diagnostic biomarker for cisplatin-based chemotherapy. High ER
Externí odkaz:
https://doaj.org/article/3d15858b6bc7446ca0436f03e8d30d17